Texas Southern Bankruptcy Court

Case number: 4:25-bk-30395 - Vyripharm Biopharmaceuticals, Inc. - Texas Southern Bankruptcy Court

Case Information
Case title
Vyripharm Biopharmaceuticals, Inc.
Chapter
11
Judge
Jeffrey P Norman
Filed
01/27/2025
Last Filing
06/24/2026
Asset
Yes
Vol
v
Docket Header

PlnDue, DsclsDue




U.S. Bankruptcy Court
Southern District of Texas (Houston)
Bankruptcy Petition #: 25-30395

Assigned to: Bankruptcy Judge Jeffrey P Norman
Chapter 11
Voluntary
Asset


Date filed:  01/27/2025
341 meeting:  03/03/2025
Deadline for filing claims:  04/07/2025
Deadline for filing claims (govt.):  07/28/2025

Debtor

Vyripharm Biopharmaceuticals, Inc.

7205 Almeda Road, Suite 300591
Houston, TX 77054
HARRIS-TX
Tax ID / EIN: XX-XXXXXXX

represented by
Susan Tran Adams

Tran Singh LLP
2502 La Branch Street
Houston, TX 77004
832-975-7300
Fax : 832-975-7301
Email: [email protected]

Trustee

Melissa A Haselden

Haselden Farrow PLLC
Pennzoil Place
700 Milam
Suite 1300
Houston, TX 77002
832.819.1149

 
 
U.S. Trustee

US Trustee

Office of the US Trustee
515 Rusk Ave
Ste 3516
Houston, TX 77002
713-718-4650
represented by
Hector Duran, Jr

U.S. Trustee
515 Rusk
Ste 3516
Houston, Tx 77002
7137184650
Email: [email protected]

Latest Dockets
Date Filed#Docket Text
06/24/202671Docket Text
Chapter 11 Subchapter V Trustees Report of No Distribution. Funds Collected: $0.00. Key information about this case as reported in schedules filed by the debtor(s) or otherwise found in the case record: This case was pending for 17 months. Assets Abandoned (without deducting any secured claims): Not Applicable, Assets Exempt: Not Applicable, Claims Scheduled: $0.00, Claims Asserted: Not Available, Claims scheduled to be discharged without payment (without deducting the value of collateral or debts excepted from discharge): Not Applicable. (Haselden, Melissa)
06/02/2026Docket Text
Bankruptcy Case Closed (bli4)
02/26/202670Docket Text
BNC Certificate of Mailing. (Related document(s):[69] Order on Application for Compensation) No. of Notices: 2. Notice Date 02/26/2026. (Admin.)
02/24/202669Docket Text
Order Approving Application For Compensation (Related Doc # [66]). Approving for Melissa A Haselden Signed on 2/24/2026. (trc4)
02/02/202668Docket Text
Declaration re: Declaration of Mailing (Filed By Melissa A Haselden ).(Related document(s):[67] Notice) (Haselden, Melissa)
01/29/202667Docket Text
Notice NOTICE OF FILING FIRST AND FINAL FEE APPLICATION OF MELISSA A. HASELDEN AND HASELDEN FARROW, PLLC. (Related document(s):[66] Application for Compensation) Filed by Melissa A Haselden (Haselden, Melissa)
01/29/202666Docket Text
Final Application for Compensation for Melissa Anne Haselden, Trustee Chapter 11, Period: 1/29/2025 to 1/21/2026, Fee: $5,201.00, Expenses: $0.00. Objections/Request for Hearing Due in 21 days. Filed by Attorney Melissa Anne Haselden Hearing scheduled for 3/3/2026 at 11:00 AM at Houston, Courtroom 403 (JPN). (Attachments: # (1) Proposed Order) (Haselden, Melissa)
01/29/202665Docket Text
Debtor-In-Possession Monthly Operating Report for Filing Period ending 12/31/2025, $0 disbursed (Filed By Vyripharm Biopharmaceuticals, Inc. ). (Adams, Susan)
01/29/202664Docket Text
Debtor-In-Possession Monthly Operating Report for Filing Period ending 11/30/2025, $0 disbursed (Filed By Vyripharm Biopharmaceuticals, Inc. ). (Adams, Susan)
01/23/202663Docket Text
BNC Certificate of Mailing. (Related document(s):[62] Order Dismissing Debtor(s)) No. of Notices: 5. Notice Date 01/23/2026. (Admin.)